CC
ASTH icon

Centiva Capital’s Astrana Health ASTH Stock Holding History

Centiva Capital’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,428
Closed -$210K – 2074
2025
Q2 		$210K Sell
8,428
-2,257
-21% -$63.6K 0.01% 1323
2025
Q1 		$331K Sell
10,685
-559
-5% -$18.6K 0.02% 1028
2024
Q4 		$355K Buy
+11,244
New +$534K 0.01% 1040
2024
Q1 		– Sell
-5,914
Closed -$227K – 2388
2023
Q4 		$227K Buy
+5,914
New +$197K 0.01% 1358
2023
Q2 		– Sell
-6,361
Closed -$232K – 2106
2023
Q1 		$232K Buy
+6,361
New +$223K 0.01% 1165

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.19B AUM 27.77% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return